Afuco™ Anti-Human IL17A ADCC Therapeutic Antibody (ANB004), ADCC Enhanced
Anti-IL17A ADCC Enhanced Antibody (ANB004) is an ADCC enhanced antibody produced by our Afuco™ platform. ANB004 is a novel anti-IL17 monoclonal antibody used for the treatment of autoimmune and inflammatory conditions. Recent clinical data has validated the therapeutic benefit of IL17 blockade in treatment of a number of autoimmune and inflammatory diseases, notably psoriasis, rheumatoid arthritis and uveitis.
| Supplier | Creative Biolabs |
|---|---|
| Product # | AFC-383CL |
| Pricing | Inquiry |
| Host | Human |
| Target | IL17A |
| Species Reactivity | Human |
| Type | ADCC enhanced antibody |
| Storage | Store the antibody (in aliquots) at -20°C. Avoid repeated freezing and thawing of samples. |